# Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance

> **NCT01690247** · PHASE1 · UNKNOWN · sponsor: **Beijing 302 Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Evidence of Liver Transplantation

## Interventions

- **DRUG:** Conventional plus UC-MSC
- **DRUG:** Conventional plus placebo

## Key facts

- **NCT ID:** NCT01690247
- **Lead sponsor:** Beijing 302 Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2014-02
- **Final completion:** 2015-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2013-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01690247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01690247, "Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01690247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*